
Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance
Author(s) -
Erin Hinchcliff,
Anca Chelariu-Raicu,
Shan N. Westin
Publication year - 2020
Publication title -
current opinion in obstetrics and gynecology/current opinion in obstetrics and gynecology, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.786
H-Index - 73
eISSN - 1080-8256
pISSN - 1040-872X
DOI - 10.1097/gco.0000000000000678
Subject(s) - medicine , cancer research , clinical trial , synthetic lethality , dna repair , biology , genetics , dna
To highlight relevant strategies to overcome poly(ADP-ribose) polymerase (PARP) inhibitor resistance and present key clinical trials.